Optimizing warfarin reversal – an ex vivo study
- 1 July 2009
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 7 (7) , 1123-1127
- https://doi.org/10.1111/j.1538-7836.2009.03435.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammationBritish Journal of Haematology, 2008
- Prothrombin complex concentrate (Beriplex® P/N) for emergency anticoagulation reversal: a prospective multinational clinical trialJournal of Thrombosis and Haemostasis, 2008
- Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulationThrombosis Research, 2008
- Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitroThrombosis and Haemostasis, 2008
- Relationship between thrombin generation and international normalized ratio in patients receiving oral vitamin K antagonist therapyJournal of Thrombosis and Haemostasis, 2007
- In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxabanJournal of Thrombosis and Haemostasis, 2007
- Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: An open, prospective randomized controlled trialThrombosis Research, 2006
- Optimisation of the prothrombin complex concentrate dose for warfarin reversalThrombosis Research, 2005
- Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin timeJournal of Thrombosis and Haemostasis, 2004
- International Normalized Ratios (INR): the first 20 yearsJournal of Thrombosis and Haemostasis, 2004